These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 31553697

  • 1. Adverse effects of stimulant medications in children and adolescents: focus on cardiovascular issues.
    Greydanus DE, Cates KW, Sadigh N.
    Int J Adolesc Med Health; 2019 Aug 30; 31(3):. PubMed ID: 31553697
    [No Abstract] [Full Text] [Related]

  • 2. Cardiovascular risk of stimulant treatment in pediatric attention-deficit/hyperactivity disorder: update and clinical recommendations.
    Hammerness PG, Perrin JM, Shelley-Abrahamson R, Wilens TE.
    J Am Acad Child Adolesc Psychiatry; 2011 Oct 30; 50(10):978-90. PubMed ID: 21961773
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Cardiovascular safety of stimulants in children with attention-deficit/hyperactivity disorder: a nationwide prospective cohort study.
    Dalsgaard S, Kvist AP, Leckman JF, Nielsen HS, Simonsen M.
    J Child Adolesc Psychopharmacol; 2014 Aug 30; 24(6):302-10. PubMed ID: 24956171
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Stimulant medications and attention deficit-hyperactivity disorder.
    Cohen AL, Jhung MA, Budnitz DS.
    N Engl J Med; 2006 May 25; 354(21):2294-5. PubMed ID: 16723627
    [No Abstract] [Full Text] [Related]

  • 7. Adverse effects of stimulant medications in children and adolescents: focus on drug abuse.
    Greydanus DE, Cates KW, Sadigh N.
    Int J Adolesc Med Health; 2019 Sep 04; 31(4):. PubMed ID: 31483757
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Attention deficit hyperactivity disorder medications in children with heart disease.
    Berger S.
    Curr Opin Pediatr; 2016 Oct 04; 28(5):607-12. PubMed ID: 27261563
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. FDA ponders cardiovascular risks of ADHD drugs.
    Young D.
    Am J Health Syst Pharm; 2006 Mar 15; 63(6):492-4. PubMed ID: 16522874
    [No Abstract] [Full Text] [Related]

  • 16. Summary of the practice parameter for the use of stimulant medications in the treatment of children, adolescents, and adults.
    Greenhill LL, Pliszka S, Dulcan MK, Bernet W, Arnold V, Beitchman J, Benson RS, Bukstein O, Kinlan J, McClellan J, Rue D, Shaw JA, Stock S, Kroeger K.
    J Am Acad Child Adolesc Psychiatry; 2001 Nov 15; 40(11):1352-5. PubMed ID: 11699811
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Long-term safety of stimulant medications used to treat children with ADHD.
    Lerner M, Wigal T.
    Pediatr Ann; 2008 Jan 15; 37(1):37-45. PubMed ID: 18240852
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.